Malignant Pleural Mesothelioma: Is Tailoring the Second-Line Therapy Really "Raising the Bar?"

Current Treatment Options in Oncology
Vincenzo Di NoiaEttore D'Argento

Abstract

Unresectable or relapsed malignant pleural mesothelioma (MPM) has dismal prognosis. First-line combination therapy with pemetrexed and a platinum analog allows a modest survival benefit, while no clear therapeutic options exist for the second-line therapy. In this setting, pemetrexed seems to be the most active drug; however, the inclusion in front-line treatment limits its use in further lines. Nevertheless, rechallenge with one or both drugs used in first-line remains a feasible strategy for responder patients. Alternatively, only few cytotoxic drugs have demonstrated a mild activity in refractory MPM. Among other options, targeted therapy has unfortunately produced disappointing results as salvage treatment probably due to the lack of a clear understanding of the tumor biology. In contrast, recent data suggest moderate efficacy and mild toxicity of immunotherapy also for the treatment of MPM. The combination of checkpoint inhibitors with chemotherapy or other immunological agents seems promising and could really "raise the bar" in this setting.

References

Jan 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·K Chang, I Pastan
Apr 1, 1996·Cancer·A CavazzaT V Colby
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J ByrneB W Robinson
Mar 5, 2002·British Journal of Cancer·J M W van HaarstJ P van Meerbeeck
Aug 22, 2002·British Journal of Cancer·A K NowakB W S Robinson
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicholas J VogelzangPaolo Paoletti
Apr 13, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C ManegoldN J Vogelzang
Jun 1, 2005·American Journal of Clinical Oncology·Bruno CastagnetoG Sinaccio
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yaqoob AliElizabeth A Poplin
Nov 17, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Sujith R KalmadiErnest C Borden
Apr 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jacek JassemChristian Manegold
May 20, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Justin StebbingJeremy P C Steele
Jul 3, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Armando SantoroChristian Manegold
Dec 20, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Suresh S RamalingamDavid Gandara
Apr 8, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Stefania CrispiAlessandra Verdina
Jun 8, 2010·The European Respiratory Journal·P E Van SchilUNKNOWN European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group
Aug 26, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sarita DubeyHedy Lee Kindler
Jan 11, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Giovanni L CeresoliArmando Santoro
Jul 9, 2011·The European Respiratory Journal·A W MuskN H de Klerk
Sep 23, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·P A ZucaliM Garassino
Oct 19, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Scott A LaurieLesley Seymour
Jul 27, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Nicholas P CampbellHedy L Kindler
Aug 17, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Dean A FennellPaul Baas
Apr 11, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sophie PapaJames Spicer
Nov 13, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Emilio MinatelMauro G Trovo
Jun 14, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Aaron Scott MansfieldEugene D Kwon
Jun 15, 2014·The Annals of Thoracic Surgery·Emanuela TaioliRaja M Flores
Jan 23, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sai-Hong Ignatius OuDavid R Gandara
Feb 7, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Masaki NasuMichele Carbone
Oct 6, 2015·Nature Medicine·Lindsay M LaFaveRoss L Levine
Nov 13, 2015·American Journal of Clinical Oncology·Elizabeth I Buchbinder, Anupam Desai
Jun 22, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andreas RimnerLee M Krug
Oct 25, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Paul Wheatley-PricePenelope A Bradbury
Sep 12, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Federica GrossoGiorgio Scagliotti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
B CastagnetoM Mencoboni
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Jens Benn SørensenAnne-Kathrine Thielsen
© 2022 Meta ULC. All rights reserved